• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS TOTAL PSA, TOTAL (FREE + COMPLEXED) PSA - PROSTATE-SPECIFIC ANTIGEN (TPSA); TOTAL,PROSTATE SPECIFIC ANTIGEN(NONCOMPLEXED&COMPLEXED) FOR DETECTION OF PROS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS TOTAL PSA, TOTAL (FREE + COMPLEXED) PSA - PROSTATE-SPECIFIC ANTIGEN (TPSA); TOTAL,PROSTATE SPECIFIC ANTIGEN(NONCOMPLEXED&COMPLEXED) FOR DETECTION OF PROS Back to Search Results
Catalog Number ASKU
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/17/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).This event occurred in (b)(6).
 
Event Description
The customer experienced an issue where the elecsys free psa immunoassay results were higher than the elecsys total psa immunoassay results for two samples from one patient.The customer used the cobas e 411 immunoassay analyzer serial number (b)(4).For the initial sample, the free psa result was 5.56 ng/ml and the total psa result was 0.25 ng/ml.The initial sample was repeated.The free psa result was 5.77 ng/ml and the total psa result was 0.23 ng/ml.The initial sample was repeated with an automatic 1:2 dilution.The free psa result was 5.78 ng/ml and the total psa result was 0.27 ng/ml.For the initial sample tested with the abbott method, the free psa result was 0.08 ng/ml and the total psa result was 0.56 ng/ml.On (b)(6) 2018 a new sample was collected from the patient.The free psa result was 5.43 ng/ml and the total psa result was 0.24 ng/ml.No erroneous results were reported outside of the laboratory.There was no allegation of an adverse event.This medwatch will cover the total psa results.(b)(4).
 
Manufacturer Narrative
The patient sample was submitted for investigation.The customer¿s results of free psa and total psa are reproducible and their complaint has been confirmed.The investigation was performed by adding an additional anti-psa antibody of a different specificity and the concentration of total psa was greater than 2.84 ng/ml.The investigation determined that the false low total psa results were due to one or more interfering components.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TOTAL PSA, TOTAL (FREE + COMPLEXED) PSA - PROSTATE-SPECIFIC ANTIGEN (TPSA)
Type of Device
TOTAL,PROSTATE SPECIFIC ANTIGEN(NONCOMPLEXED&COMPLEXED) FOR DETECTION OF PROS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key7503473
MDR Text Key108249969
Report Number1823260-2018-01445
Device Sequence Number1
Product Code MTF
Combination Product (y/n)N
PMA/PMN Number
P990056
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 06/12/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/10/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberASKU
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Date Manufacturer Received04/24/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age36 YR
-
-